Collection of blood, urine, and tissue samples for research on skin conditions
Peripheral Blood, Urine and Skin Sample Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
This study is collecting blood, urine, and tissue samples from people with skin conditions like cutaneous T-cell lymphoma, eczema, and atopic dermatitis to help improve treatments in the future.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 200 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Pittsburgh Academic / other |
| Locations | 1 site (Pittsburgh, Pennsylvania) |
| Trial ID | NCT00177268 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on collecting blood, urine, and tissue samples from patients diagnosed with cutaneous T-cell lymphoma, eczema, and atopic dermatitis. The samples will be used for various research purposes, including immunologic assays, tumor progression monitoring, and genomic and proteomic studies. The goal is to create a central repository that facilitates ongoing and future research aimed at improving treatment options for these skin conditions.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older who have been diagnosed with cutaneous T-cell lymphoma, eczema, or atopic dermatitis.
Not a fit: Patients who do not have a diagnosis of cutaneous T-cell lymphoma, eczema, or atopic dermatitis will not benefit from this study.
Why it matters
Potential benefit: If successful, this research could lead to advancements in the treatment and understanding of cutaneous T-cell lymphoma, eczema, and atopic dermatitis.
How similar studies have performed: Other studies involving tissue and blood banking for similar conditions have shown promise in advancing research, making this approach both relevant and potentially impactful.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18 or older * able and willing to provide informed consent * diagnosed with CTCL * diagnosed with either atopic dermatitis or eczema Exclusion Criteria: * Lack of CTCL, atopic dermatitis, or eczema diagnosis in medical record
Where this trial is running
Pittsburgh, Pennsylvania
- University of Pittsburgh Medical Center — Pittsburgh, Pennsylvania, United States (Recruiting)
Study contacts
- Principal investigator: Oleg E Akilov, M.D., PhD — University of Pittsburgh
- Study coordinator: Charity L Ruhl, LPN
- Email: ruhlcl@upmc.edu
- Phone: 4126472013
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.